Event Date/Time: Mar 21, 2006
End Date/Time: Mar 22, 2006
Polymorphism & crystallisation is a critically important area for pharma companies – with the potential to lose millions if they don’t get it right. Pharma IQ’s London Polymorphism & Crystallisation Forum is now in it’s 3rd year and is the largest, most established dedicated meeting globally. The 2006 event will again be focusing on scientific, technical and IP issues, bringing delegates recent case studies and up-to-the minute research from leading figured including Joel Bernstein. It will provide insight into recent patent litigation, identification and characterisation techniques, amorphous materials, strategies to control polymorphism, and in addition it will feature a unique focus day looking at the development and use of pharmaceutical co-crystals.